Onconetix Total Risk Alpha
| ONCO Stock | | | USD 3.22 0.19 6.27% |
This module presents the Total Risk Alpha indicator for Onconetix using available market inputs. This dataset is part of a broader indicator framework including
Equity Screeners. Onconetix has a market cap of 2.06 M, operating margin of -4.22%, current ratio of 0.62.
Your Equity Center adds portfolio-level perspective. Including Onconetix in a portfolio enables allocation and risk analysis. Each holding is sized according to the methodology applied during portfolio construction. Broader economic conditions can influence Onconetix's company valuation — related indicators include
signals in discontinued.
Researching Onconetix Stock? See our
How to Buy Onconetix guide. The guide includes approaches for both long-term investing and shorter-term trading of Onconetix Stock. The guide provides a structured overview of the trading process for Onconetix.
Onconetix has current Total Risk Alpha of
-0.42. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | -0.42 | |
| ER[a] | = | Expected return on investing in Onconetix |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Onconetix |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Onconetix is rated
below average in total risk alpha compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Onconetix to Peers
Other Technical Indicators